Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Benson and Britten examined why patients choose to take drug
treatment for hypertension and expose the ambivalence some people feel
about pharmaceutical intervention for chronic disease.1 We
have recently completed a study looking at the reasons a notable
proportion of diagnosed hypertensive patients does not return for
follow up appointments.
We identified 35 such non-returners in populations from three general practices in Worcester, Droitwich, and Exmouth (approximately 5% of the hypertension registers). Eleven of these patients (age 30-75, median age 62, 6 male, 5 female) were interviewed in their homes and asked their views on their diagnosis, follow up, and treatment options. We analysed transcripts by using standard qualitative techniques.
Many of the themes we identified fit well with those described, notably
the dislike of medication and fear of being labelled as sick. We also
noted that many of the patients had wider concerns about how regular
follow up would affect their perception
Read all Rapid Responses